First professional · Baltimore, Maryland

Is Pharmacy, Pharmaceutical Sciences, and Administration at Notre Dame of Maryland University worth it?

Medium confidence Medium confidence: 40–99 graduates behind the earnings figures.

The verdict · all families, in-state, half paid with loans

Pays back slowly: graduates typically recover the cost in about 7.3 years.

Earnings 1 year after graduating: $92,249; Treasury AY2020-21, AY2021-22 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Earnings 4 years after graduating: $139,753; Treasury AY2017-2018, AY2018-2019 pooled earnings cohort measured in CY2022, CY2023, inflation adjusted to 2024 dollars
Typical federal debt at graduation: $257,924; NSLDS pooled AY2022-23, AY2023-24 cohort
Typical borrowing (no graduate net price is published): $273k (likely $273k – $273k); AcadYr 2024-25, reported in IPEDS DCY2025-26
Earnings bump, year 4: $73k a year vs bachelor's graduates 4 years out in MD; 2023 ACS 5-year pooled, adjusted to 2024 dollars
Payback: 7.3 years (likely 6.2–9.0); Bump vs net cost plus loan interest
10-year net return: −$69k (likely −$229k – $87k); Today's dollars
20-year net return: $803k (likely $472k – $1.17M); Today's dollars
Borrowers making progress / in default, 2 years in: ≤ 20% / ≤ 20%; NSLDS AY2016-17, AY2017-18 pooled cohorts measured in 2018-19, 2019-20

Scorecard reports no net price for graduate programs; cost is based on what graduates typically borrowed.